NDC Pharmacologic Class N0000193944 Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0310-0610Koselugo SelumetinibCapsuleOralAstrazeneca Pharmaceuticals LpHuman Prescription Drug
0310-0625Koselugo SelumetinibCapsuleOralAstrazeneca Pharmaceuticals LpHuman Prescription Drug

There are 2 NDC products with the pharmacologic class Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA].